Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference
Aclaris Therapeutics, Inc. WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candida...